Health Announces when Several Menopause Drugs Suffering From Supply Problems Will Return to Pharmacies
6 Articles
6 Articles
The Spanish Agency for Medicines and Health Products (AEMPS) has announced new measures to address the supply problems of several hormonal drugs used mainly to treat the symptoms of menopause. The lack of stocks affects treatments that contain estradiol, a hormone that helps compensate for the decrease of estrogens in the body.
Noticias de Navarra
The supply of Lenzetto, a transdermal oestradiol spray solution used as hormonal treatment for menopause, will begin to be progressively restored in mid-November. Its normalization is expected during 2027, according to the estimates of the marketing company, Gedeon Richter, reported by the Spanish Agency for Medicines and Health Products (AEMPS).
The Spanish Agency for Medicines and Health Products (AEMPS), under the Ministry of Health, has reported that the supply of 'Lenzetto' 1.52 mg/dose, a transdermal spray solution used in hormone replacement therapy for the treatment of menopause, will begin to be progressively restored from mid-November and will be normalized throughout 2027, according to the forecasts of the marketing company, Gideon Richter.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
